Open AccessDoes Hepatitis C Treatment Adherence Affect Risk of Liver Transplantation? A Historical Cohort Study
Author(s) -
Derek Ems,
Patrick Racsa,
Chris Anderson,
Fran Gregory,
Kim C. Worley,
Joel V. Brill,
W S Holt
Publication year - 2016
Publication title -
journal of managed care and specialty pharmacy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.126
H-Index - 63
eISSN - 2376-1032
pISSN - 2376-0540
DOI - 10.18553/jmcp.2016.22.7.863
Subject(s) - medicine , liver transplantation , hepatitis c , population , cohort , transplantation , cohort study , medical prescription , intensive care medicine , environmental health , pharmacology
Chronic hepatitis C virus (HCV) is the primary cause of liver failure leading to transplantation, and medication adherence is essential to the therapeutic efficacy of HCV treatments. While there is evidence linking poor adherence with increased utilization and cost, published literature lacks examination of the association between medication adherence and risk of liver transplant. In addition, the impact of HCV treatment on total costs of liver transplantation is not well documented.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom